{"id":"NCT00546351","sponsor":"UCB Pharma","briefTitle":"Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy.","officialTitle":"A Multi-center, Open-label, follow-on Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy Including a Double-blind, Randomized Time Point Withdrawal Subtrial.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-05","primaryCompletion":"2011-01","completion":"2011-01","firstPosted":"2007-10-18","resultsPosted":"2012-04-19","lastUpdate":"2023-09-21"},"enrollment":621,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Painful Diabetic Neuropathy"],"interventions":[{"type":"DRUG","name":"Lacosamide","otherNames":["Vimpat"]}],"arms":[{"label":"Lacosamide","type":"EXPERIMENTAL"}],"summary":"SP746 (NCT00546351) is a multi-center, open-label, follow-on trial. The purpose of this trial is to assess safety and tolerability of long-term exposure of lacosamide (previously referred to as SPM 927) in subjects with painful distal diabetic neuropathy.","primaryOutcome":{"measure":"Number of Participants Experiencing the Occurrence of at Least One Treatment-emergent Adverse Event (TEAE) During the Evaluation Period From Entry Visit 1 Through End of Treatment (Approximately 6.5 Years).","timeFrame":"From entry Visit 1 through end of treatment (approximately 6.5 years)","effectByArm":[{"arm":"Lacosamide","deltaMin":416,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":101,"countries":["Austria","Belgium","Bulgaria","Czechia","Finland","France","Germany","Hungary","Italy","Poland","Romania","Russia","Serbia","Spain","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":132,"n":621},"commonTop":["Nasopharyngitis","Dizziness","Hypertension","Headache","Vertigo"]}}